Adaptive Biotechnologies to receive up to $250M in financing deal By: Puget Sound Business Journal (Seattle) via Business Journals September 14, 2022 at 17:22 PM EDT The Seattle-based biotech can tap three tranches of funding under an agreement with health care investment firm OrbiMed. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
